Obese and diabetic? There’s a shot for you


Dr Mads Krogsgaard Thomsen speaking to international media at the Novo Nordisk Favrholm campus in Denmark. He observed that once countries become obese, there is a lag time of about 10 years before the resultant increase in diabetes. - Novo Nordisk

Danish pharmaceutical company Novo Nordisk tackles both obesity and diabetes in their current drug pipeline.

Being overweight or obese has long been known to be a risk factor for type 2 diabetes.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

E-cigarettes likely cause lung and oral cancer
Tips to keep your skin hydrated
Is it safe to deliver chemotherapy at home?
Going nuclear on disease to both diagnose and treat
This diabetes drug affects the brain
Why civic sense is a mental health issue
Using his toe as a thumb
Why nitric oxide is important for our health
Sperms struggle to get to the egg in space
Helping seniors stay safe in the heat�

Others Also Read